Movement Alert｜Kelun-Biotech Falls 3.08% in Regular Trading, Trading at 411.4 HKD

Market Focus

Jun 25

On June 25, Kelun-Biotech (06990.HK) fell 3.08% in regular trading, trading at 411.4 HKD/share, with turnover of 38.64 million HKD.

Within the Biotechnology sector where Kelun-Biotech belongs, the overall sector trended lower. Among individual stocks, Akeso down 3.49%, Innovent Bio down 3.66%, 3SBio down 2.38%, BeiGene down 1.09%, Remegen down 3.99%.

Kelun-Biotech is an innovative biopharmaceutical company primarily engaged in the R&D, manufacturing, and commercialization of innovative drugs in oncology, immunology, and other therapeutic areas. Its core products include antibody-drug conjugates (ADC) SKB264 and A166, mainly used for the treatment of breast cancer, non-small cell lung cancer, and gastrointestinal cancer.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1162892913"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162892913\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162892913?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 10:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162892913","market":"us","top_or_hot":-1,"title":"Movement Alert｜Kelun-Biotech Falls 3.08% in Regular Trading, Trading at 411.4 HKD","media":"Market Focus","content":"<p><p>On June 25, Kelun-Biotech (06990.HK) fell 3.08% in regular trading, trading at 411.4 HKD/share, with turnover of 38.64 million HKD.</p><p>Within the Biotechnology sector where Kelun-Biotech belongs, the overall sector trended lower. Among individual stocks, Akeso down 3.49%, Innovent Bio down 3.66%, 3SBio down 2.38%, BeiGene down 1.09%, Remegen down 3.99%.</p><p>Kelun-Biotech is an innovative biopharmaceutical company primarily engaged in the R&D, manufacturing, and commercialization of innovative drugs in oncology, immunology, and other therapeutic areas. Its core products include antibody-drug conjugates (ADC) SKB264 and A166, mainly used for the treatment of breast cancer, non-small cell lung cancer, and gastrointestinal cancer.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Kelun-Biotech Falls 3.08% in Regular Trading, Trading at 411.4 HKD</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Kelun-Biotech Falls 3.08% in Regular Trading, Trading at 411.4 HKD\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-25 10:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 25, Kelun-Biotech (06990.HK) fell 3.08% in regular trading, trading at 411.4 HKD/share, with turnover of 38.64 million HKD.</p><p>Within the Biotechnology sector where Kelun-Biotech belongs, the overall sector trended lower. Among individual stocks, Akeso down 3.49%, Innovent Bio down 3.66%, 3SBio down 2.38%, BeiGene down 1.09%, Remegen down 3.99%.</p><p>Kelun-Biotech is an innovative biopharmaceutical company primarily engaged in the R&D, manufacturing, and commercialization of innovative drugs in oncology, immunology, and other therapeutic areas. Its core products include antibody-drug conjugates (ADC) SKB264 and A166, mainly used for the treatment of breast cancer, non-small cell lung cancer, and gastrointestinal cancer.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06990","symbol_name":"科伦博泰生物","start_time":0,"source_url":"","article_id":"1162892913","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162892913","pubTimestamp":1782353666,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 25, Kelun-Biotech (06990.HK) fell 3.08% in regular trading, trading at 411.4 HKD/share, with turnover of 38.64 million HKD.Within the Biotechnology sector where Kelun-Biotech belongs, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06990":"科伦博泰生物"},"translate_title":"异动快讯|科伦生物常规交易跌3.08%，报411.4港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06990":1},"content_text":"On June 25, Kelun-Biotech (06990.HK) fell 3.08% in regular trading, trading at 411.4 HKD/share, with turnover of 38.64 million HKD.Within the Biotechnology sector where Kelun-Biotech belongs, the overall sector trended lower. Among individual stocks, Akeso down 3.49%, Innovent Bio down 3.66%, 3SBio down 2.38%, BeiGene down 1.09%, Remegen down 3.99%.Kelun-Biotech is an innovative biopharmaceutical company primarily engaged in the R&D, manufacturing, and commercialization of innovative drugs in oncology, immunology, and other therapeutic areas. Its core products include antibody-drug conjugates (ADC) SKB264 and A166, mainly used for the treatment of breast cancer, non-small cell lung cancer, and gastrointestinal cancer.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}